跳至主要内容
临床试验/NCT03831230
NCT03831230已完成不适用

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

Centre Francois Baclesse1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年3月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
250
试验地点
1
主要终点
Rates of exploitable ex vivo tumor, blood and urine samples for performing predictive tests

研究概览

简要总结

Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient over 18 years old.
  • Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically proven peritoneum. All FIGO stages are accepted for the study.
  • Patient to be managed by surgery (laparoscopy and / or laparotomy).

排除标准

  • Pregnant woman
  • Persons deprived of liberty or guardianship (including curatorship)
  • History of any other clinically active malignancy in the last 5 years prior to inclusion

结局指标

主要结局

Rates of exploitable ex vivo tumor, blood and urine samples for performing predictive tests

时间窗: Collection of blood, urine, tumor and ascite samples at the time of ovarian surgery

Number and quality of tumor, blood and urine samples that can be used to perform predictive tests of the response to treatment

次要结局

未报告次要终点

研究者

发起方
Centre Francois Baclesse
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验